Release of annexin V-binding membrane microparticles from cultured human umbilical vein endothelial cells after treatment with camptothecin -: art. no. 11

被引:74
作者
Simák, J [1 ]
Holada, K [1 ]
Vostal, JG [1 ]
机构
[1] US FDA, Lab Cellular Hematol, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA
关键词
D O I
10.1186/1471-2121-3-11
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Background: Elevated plasma counts of endothelial micoparticles (MP) have been demonstrated in various diseases with a vascular injury component. We used flow cytometry to study the MP-release from cultured human umbilical vein endothelial cells HUVEC) stimulated by various agonists. MP-release by a topoisomerase I inhibitor camptothecin has been studied in detail. Results: Overnight stimulation of HUVEC with either LPS or TNFalpha, or 30 min stimulation with thrombin, phorbol-myristate-acetate, tissue plasminogen activator, or angiotensin-II did not cause a significant release of annexin V-binding MP. In contrast, induction of apoptosis with 5 muM camptothecin, documented by 60-70% desquamation of HUVEC culture, annexin V-binding to the cells and DNA-fragmentation, led to a release of annexin V-binding MP similar to80,000 MP/10(3) cells). This MP-release was prevented by Z-Val-Ala-Asp-fluoromethyl-ketone ZVAD). Lowe concentration of camptothecin 500 nM) induced comparable MP-release without loss of the culture confluence and without increase in annexin V-binding to the cells or DNA-fragmentation. Analyzed MP were free of nucleic acids and 95% of MP were 0.3-1 mum in size. Double-labeling flow cytometry assay showed that all annexin V-binding MP expressed CD59 but only approximately 50% of these also expressed CD105. Conclusions: Camptothecin treated HUVEC released different populations of annexin V-binding membrane MP at early stage after proapoptotic stimulation before detection of phosphatidyl serine exposure on the cells of DNA fragmentation. The MP-release was ZVAD sensitive but was not enhanced at the executive phase of apoptosis. These observations offer a new insight into MP-release as a make of endothelial stimulation and injury.
引用
收藏
页数:33
相关论文
共 32 条
[1]   The significance of shed membrane particles during programmed cell death in vitro, and in vivo, in HIV-1 infection [J].
Aupeix, K ;
Hugel, B ;
Martin, T ;
Bischoff, P ;
Lill, H ;
Pasquali, JL ;
Freyssinet, JM .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 99 (07) :1546-1554
[2]  
Berckmans RJ, 2001, THROMB HAEMOSTASIS, V85, P639
[3]   Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: Implications for coagulation events and antigenic spread in systemic lupus erythematosus [J].
CasciolaRosen, L ;
Rosen, A ;
Petri, M ;
Schlissel, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (04) :1624-1629
[4]   Plasma membrane phospholipid asymmetry precedes DNA fragmentation in different apoptotic cell models [J].
Chan, A ;
Reiter, R ;
Wiese, S ;
Fertig, G ;
Gold, R .
HISTOCHEMISTRY AND CELL BIOLOGY, 1998, 110 (06) :553-558
[5]   In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant [J].
Combes, V ;
Simon, AC ;
Grau, GE ;
Arnoux, D ;
Camoin, L ;
Sabatier, F ;
Mutin, M ;
Sanmarco, M ;
Sampol, J ;
Dignat-George, F .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (01) :93-102
[6]   A1 functions at the mitochondria to delay endothelial apoptosis in response to tumor necrosis factor [J].
Duriez, PJ ;
Wong, F ;
Dorovini-Zis, K ;
Shahidi, R ;
Karsan, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (24) :18099-18107
[7]   Endoglin:: An accessory component of the TGF-β-binding receptor-complex with diagnostic, prognostic, and bioimmunotherapeutic potential in human malignancies [J].
Fonsatti, E ;
Del Vecchio, L ;
Altomonte, M ;
Sigalotti, L ;
Nicotra, MR ;
Coral, S ;
Natali, PG ;
Maio, M .
JOURNAL OF CELLULAR PHYSIOLOGY, 2001, 188 (01) :1-7
[8]   ROLE OF THE MEMBRANE SKELETON IN PREVENTING THE SHEDDING OF PROCOAGULANT-RICH MICROVESICLES FROM THE PLATELET PLASMA-MEMBRANE [J].
FOX, JEB ;
AUSTIN, CD ;
BOYLES, JK ;
STEFFEN, PK .
JOURNAL OF CELL BIOLOGY, 1990, 111 (02) :483-493
[9]  
Garcia-Carbonero R, 2002, CLIN CANCER RES, V8, P641
[10]  
Gidon-Jeangirard C, 1999, J IMMUNOL, V162, P5712